Sinovac Biotech Ltd.
SVA · NASDAQ
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$258 | $88 | $14,459 | $185 |
| Dep. & Amort. | $145 | $157 | $87 | $4 |
| Deferred Tax | $76 | -$83 | $265 | -$11 |
| Stock-Based Comp. | $0 | $0 | $8 | $10 |
| Change in WC | $278 | -$1,081 | $461 | $283 |
| Other Non-Cash | -$135 | -$1 | $73 | $8 |
| Operating Cash Flow | $104 | -$771 | $15,353 | $479 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$146 | -$403 | -$720 | -$128 |
| Net Acquisitions | $0 | $9 | -$14 | $541 |
| Inv. Purchases | -$8,356 | -$11,658 | -$8,827 | -$202 |
| Inv. Sales/Matur. | $5,575 | $6,328 | $6,567 | $125 |
| Other Inv. Act. | $0 | -$35 | -$31 | -$541 |
| Investing Cash Flow | -$2,926 | -$5,760 | -$3,024 | -$205 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $239 | -$4 | -$26 | $33 |
| Stock Issued | $1 | $0 | $1 | $2 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | -$328 | -$263 | -$1,876 | $0 |
| Other Fin. Act. | $12 | $26 | $4 | $17 |
| Financing Cash Flow | -$76 | -$241 | -$1,897 | $593 |
| Forex Effect | -$115 | -$561 | $137 | $27 |
| Net Chg. in Cash | -$3,011 | -$7,333 | $10,570 | $894 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $4,286 | $11,620 | $1,050 | $156 |
| End Cash | $1,275 | $4,286 | $11,620 | $1,050 |
| Free Cash Flow | -$42 | -$1,174 | $14,633 | $352 |